Sunscreen Firm Warned, Natural Balms Among Recent Recalls: Consumer Health News
Korean OTC firm Seidni has GMP, sunscreen labeling problems; DXM abuse by teens remains at 3%, annual survey shows; GMP deviations among reasons behind recent OTC recalls.
You may also be interested in...
US House legislation banning the sale of DXM OTCs to consumers under age 18 likely stands the same chance right now as previous versions that have failed, but CHPA expects an increasing number of state laws could spur future action.
Approved in February as an on-demand remedy, Nurtec will be filed for migraine prevention after success in Phase III. It could be the first oral preventive therapy and first dual purpose migraine drug.
A protocol amendment is not needed to pause enrollment to decrease potential exposure to COVID-19, and virtual visits can be immediately implemented to ensure safety; experts say pandemic is forcing a rethinking in how companies carry out trials and in how regulators ensure patient safety and trial integrity.